New therapeutic "cocktails" could offer long-lasting relief for treatment-resistant asthma and other inflammatory diseases of ...
Hosted on MSN1mon
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma, other inflammatory diseasesThe cocktails inhibit key molecules (called ICOSL, OX40L, and CD30L) that they found allow specialized tissue-resident memory T cells to stay active and maintained in high numbers in tissues.
The cocktails inhibit key molecules (called ICOSL, OX40L, and CD30L) that they found allow specialized tissue-resident memory T cells to stay active and maintained in high numbers in tissues.
The cocktails inhibit key molecules (called ICOSL, OX40L, and CD30L) that they found allow specialized tissue-resident memory T cells to stay active and maintained in high numbers in tissues. Without ...
The cocktails inhibit key molecules (called ICOSL, OX40L, and CD30L) that they found allow specialized tissue-resident memory T cells to stay active and maintained in high numbers in tissues.
The problematic molecules—ICOSL, OX40L, and CD30L—keep memory T cells in the lungs on high alert. While typically these T cells are beneficial, preserving information about past infections to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback